. 2023 Oct 19;19(4):379–387. doi: 10.1177/17474930231207777
© 2023 World Stroke Organization
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Figure 1.
Targeting residual risk of inflammation for secondary stroke prevention.